Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,638 | 25,037 | 35,287 | 51,986 | 68,135 |
| Other current assets | 67 | 67 | 67 | 117 | 117 |
| TOTAL | $17,507 | $26,058 | $36,914 | $54,994 | $70,998 |
| Non-Current Assets | |||||
| PPE Net | 507 | 541 | 559 | 568 | 414 |
| Other Non-Current Assets | 3,075 | 3,111 | 3,229 | 3,164 | 3,231 |
| TOTAL | $3,582 | $3,651 | $3,788 | $3,732 | $3,645 |
| Total Assets | $21,089 | $29,709 | $40,702 | $58,726 | $74,643 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,473 | 1,599 | 2,958 | 5,473 | 2,759 |
| Accrued Expenses | 796 | 1,085 | 1,188 | 727 | 1,329 |
| TOTAL | $4,574 | $4,287 | $6,045 | $8,926 | $5,765 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 714 | 712 | 712 | 1,244 | 1,244 |
| Other Non-Current Liabilities | 2,120 | 2,247 | 2,371 | 2,491 | 2,605 |
| TOTAL | $4,435 | $4,747 | $5,051 | $3,747 | $4,163 |
| Total Liabilities | $9,009 | $9,034 | $11,097 | $12,674 | $9,928 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,872 | 7,304 | 6,888 | 6,888 | 6,881 |
| Common Shares | 7 | 207 | 207 | 207 | 7 |
| Retained earnings | -326,852 | -314,625 | -304,864 | -287,380 | -267,604 |
| Other shareholders' equity | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $12,080 | $20,675 | $29,605 | $46,052 | $64,715 |
| Total Liabilities And Equity | $21,089 | $29,709 | $40,702 | $58,726 | $74,643 |